Tibet Weixinkang Medicine Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 499.908 million compared to CNY 281.349 million a year ago. Operating income was CNY 65.645 million compared to CNY 29.115 million a year ago. Net income was CNY 53.325 million compared to CNY 29.407 million a year ago. Basic earnings per share from continuing operations was CNY 0.13 compared to CNY 0.07 a year ago.